Remove Cannabinoids Remove Data Remove Extraction Remove Sativa
article thumbnail

Avicanna Completes First Commercial Export of Aureus Branded Full Spectrum Psychoactive CBD Cannabis Extracts to Brazil

Cannabis Law Report

This initial export to Brazil marks Avicanna ’s first commercial export of psychoactive Cannabis Extracts into the emerging Brazilian medicinal cannabis market and the delivery of the initial purchase order from the previously announced three (3) year master supply agreement.

article thumbnail

Avicanna Completes First Commercial Export of Aureus™ Branded THC Extracts to Austria and Welcomes Colombian Government’s Progressive New Regulation on Cannabis

Cannabis Law Report

This initial export to Austria marks Avicanna’s first commercial export of psychoactive THC Cannabis Extracts into the emerging European medicinal cannabis market. Initial shipment of THC extracts into the European Union. New progressive regulation on cannabis in Colombia.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

German Government Now Funding Research Into CBD Extracts

SpeedWeed

The German government is now funding cannabis research on cannabinoid extractions and additives to food. Until last fall, the reality, technically, was that the entire plant (Cannabis Sativa L) was considered a “narcotic” at the European level. That is a big story. . Novel Food regulation also covers this part of the discussion.

article thumbnail

Marijuana & COVID-19: New Study Preview

CannaMD

As the study authors acknowledge: Cannabis sativa, especially one high in the anti-inflammatory cannabinoid cannabidiol (CBD), has been proposed to modulate gene expression and inflammation and is under investigation for several potential therapeutic applications against cancer and various inflammatory diseases. Why Study Marijuana?

article thumbnail

Clever Leaves and Biopharmaceutical Research Company to Partner for Landmark Cannabis Research Study in Collaboration with the University of California, Davis

Cannabis Law Report

NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, and Biopharmaceutical Research Company (“BRC”), a specialty pharmaceutical company that holds federal licenses for importing, analyzing and manufacturing controlled substances in the U.S.,

article thumbnail

Largest Human Trial To Date Will Review Safety Of Full Spectrum Hemp Products

SpeedWeed

As is the case in the United States, Europe lacks sufficiently reliable scientific data to support the safety of products infused with full spectrum hemp extract. In January 2019, the European Union (EU) reclassified extracts of cannabis sativa L. Read the entire article at The Fresh Toast.

Safety 52
article thumbnail

Marijuana & COVID-19: Top Studies [August 2020]

CannaMD

Marijuana cannabinoid, CBD. While future research is needed, the present study opens up a new landscape for marijuana research – focusing on terpenes just as much as cannabinoids. Hypothesizing that high-CBD cannabis extracts may be used to modulate ACE2 expression in COVID- 19 target tissues, researchers went to work.